Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL.
Han Q, Gu Y, Xiang H, Zhang L, Wang Y, Yang C, Li J, Steiner C, Lapalombella R, Woyach JA, Yang Y, Dovat S, Song C, Ge Z.
Han Q, et al.
Blood. 2024 Dec 27:blood.2024024130. doi: 10.1182/blood.2024024130. Online ahead of print.
Blood. 2024.
PMID: 39785511